Nasiru Moro

Recent publications · Crossref

5 total works indexed

1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

   · 2018 · cited 3,173x

2. Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

   · 2013 · cited 2,876x

3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

   · 2024 · cited 2,313x

4. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

   · 2024 · cited 2,299x

5. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,863x

via Crossref · CC0